Lista de obras - Silvio Marco Veronese - Dominio Público Uruguay

A case of compound mutations in the MYBPC3 gene associated with biventricular hypertrophy and neonatal death.

artículo científico publicado en 2012

A quantitative-PCR protocol rapidly detects αGAL deletions/duplications in patients with Anderson-Fabry disease.

artículo científico publicado en 2012

Absence of c-Kit and members of the epidermal growth factor receptor family in refractory germ cell cancer

scientific article published on 01 June 2003

Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.

artículo científico publicado en 2006

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer

artículo científico publicado en 2013

Assessment of a HER2 scoring system for colorectal cancer: results from a validation study

artículo científico

Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up

artículo científico publicado en 1996

Bing Neel Syndrome in a Previously Untreated Patient With Waldenström's Macroglobulinemia: Contribution of MYD88 L265P Mutation on Cerebrospinal Fluid

artículo científico publicado en 2015

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

artículo científico publicado en 2017

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

artículo científico publicado en 2014

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.

artículo científico publicado en 2015

Detection of circulating tumor DNA in early- and late-stage human malignancies

artículo científico publicado en 2014

Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment

scientific article published on 01 February 2007

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

artículo científico publicado en 2016

EGFR FISH in colorectal cancer: what is the current reality?

artículo científico publicado en 2008

Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis

artículo científico publicado en 2017

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

artículo científico publicado en 2012

Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab

scientific article published on 01 August 2007

Epitope recognition in the human-pig comparison model on fixed and embedded material

artículo científico publicado en 2015

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

artículo científico publicado en 2013

Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

scientific article published on 01 July 2015

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

artículo científico publicado en 2005

Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism as a potential novel metabolism in chronic lymphocytic leukemia.

artículo científico publicado en 2011

Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function.

artículo científico publicado en 2015

High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.

artículo científico publicado en 2003

Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL.

artículo científico publicado en 2013

In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody

artículo científico publicado en 1989

Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells

artículo científico publicado en 2000

Interstitial leucocyte infiltration in primary glomerulonephritis: extent and composition analysis

scientific article published on 01 January 1993

Intracranial hypotension syndrome: neuroimaging in five spontaneous cases and etiopathogenetic correlations

artículo científico publicado en 1998

KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy

artículo científico publicado en 2013

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

artículo científico publicado en 2015

Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients

artículo científico publicado en 2009

Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer

artículo científico publicado en 2009

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers

artículo científico

Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer

artículo científico publicado en 2008

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

artículo científico publicado en 2017

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

artículo científico publicado en 2014

Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer

artículo científico publicado en 2015

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

artículo científico publicado en 2007

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

artículo científico publicado en 2009

Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience

artículo científico publicado en 2017

Proliferating cell nuclear antigen expression in central nervous system neoplasms

artículo científico publicado en 1991

Role of Cetuximab in the Treatment of Patients With NSCLC: Are We Throwing Out the Baby With the Bath Water?

scientific article published on 28 June 2010

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer

artículo científico publicado en 2015

Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia?

artículo científico publicado en 2013

Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study.

artículo científico publicado en 2011

Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H.

artículo científico publicado en 2004

Successful management of deep facial burns in a patient with extensive third-degree burns: the role of a nanocrystalline silver dressing in facilitating resurfacing

artículo científico publicado en 2007

Synergistic antitumor activity of cetuximab and namitecan in human squamous cell carcinoma models relies on cooperative inhibition of EGFR expression and depends on high EGFR gene copy number

artículo científico publicado en 2013

T-cell receptor gene rearrangement in Epstein-Barr virus infectious mononucleosis.

artículo científico publicado en 2011

The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.

artículo científico publicado en 2014

The first Caucasian patient with p.Val122Ile mutated-transthyretin cardiac amyloidosis treated with isolated heart transplantation

artículo científico publicado en 2012

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets

artículo científico publicado en 2015

Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.

artículo científico publicado en 2015

ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia.

artículo científico publicado en 2010

c.428T > C (p.V143A) homozygous mutation in TP53 gene as a possible mechanism of resistance to trastuzumab therapy in gastric cancer

artículo científico publicado en 2016

p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment

article

Lista de obras de Silvio Marco Veronese

A case of compound mutations in the MYBPC3 gene associated with biventricular hypertrophy and neonatal death.

A quantitative-PCR protocol rapidly detects αGAL deletions/duplications in patients with Anderson-Fabry disease.

Absence of c-Kit and members of the epidermal growth factor receptor family in refractory germ cell cancer

Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer

Assessment of a HER2 scoring system for colorectal cancer: results from a validation study

Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up

Bing Neel Syndrome in a Previously Untreated Patient With Waldenström's Macroglobulinemia: Contribution of MYD88 L265P Mutation on Cerebrospinal Fluid

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.

Detection of circulating tumor DNA in early- and late-stage human malignancies

Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

EGFR FISH in colorectal cancer: what is the current reality?

Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab

Epitope recognition in the human-pig comparison model on fixed and embedded material

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism as a potential novel metabolism in chronic lymphocytic leukemia.

Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function.

High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.

Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL.

In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody

Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells

Interstitial leucocyte infiltration in primary glomerulonephritis: extent and composition analysis

Intracranial hypotension syndrome: neuroimaging in five spontaneous cases and etiopathogenetic correlations

KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients

Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers

Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience

Proliferating cell nuclear antigen expression in central nervous system neoplasms

Role of Cetuximab in the Treatment of Patients With NSCLC: Are We Throwing Out the Baby With the Bath Water?

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer

Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia?

Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study.

Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H.

Successful management of deep facial burns in a patient with extensive third-degree burns: the role of a nanocrystalline silver dressing in facilitating resurfacing

Synergistic antitumor activity of cetuximab and namitecan in human squamous cell carcinoma models relies on cooperative inhibition of EGFR expression and depends on high EGFR gene copy number

T-cell receptor gene rearrangement in Epstein-Barr virus infectious mononucleosis.

The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.

The first Caucasian patient with p.Val122Ile mutated-transthyretin cardiac amyloidosis treated with isolated heart transplantation

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets

Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.

ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia.

c.428T > C (p.V143A) homozygous mutation in TP53 gene as a possible mechanism of resistance to trastuzumab therapy in gastric cancer

p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment